公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M | Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen | Scientific reports | 9 | 9 | |
2022 | Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid | Liao, Pei-Ya; Ou, Wei-Fan; KANG-YI SU ; Sun, Ming-Hsi; Huang, Chih-Mei; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; SUNG-LIANG YU ; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen | Cancers | 0 | 0 | |
2023 | Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer | Wang, Chi-Liang; Hsu, Kuo-Hsuan; Chang, Ya-Hsuan; CHAO-CHI HO ; CHUN-JU CHIANG ; Chen, Kun-Chieh; Cheung, Yun-Chung; Huang, Pei-Ching; Chen, Yu-Ruei; Chen, Chih-Yi ; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chen, Hsuan-Yu; Yang, Shi-Yi; Li, Yao-Jen; Yang, Tsung-Ying; Tseng, Jeng-Sen; Chuang, Cheng-Yen; Hsiung, Chao A; Chen, Yuh-Min; Huang, Ming-Shyan; CHONG-JEN YU ; KUAN-YU CHEN ; Su, Wu-Chou; Chen, Jeremy J W; SUNG-LIANG YU ; Chen, Chien-Jen; PAN-CHYR YANG ; Tsai, Ying-Huang; Chang, Gee-Chen | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2 | 0 | |
2024 | Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study | Chang, Gee-Chen; Chiu, Chao-Hua; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Chang, Ya-Hsuan; Hsu, Kuo-Hsuan; Wu, Yu-Chung; CHIH-YI CHEN ; Hsu, Hsian-He; Wu, Ming-Ting; Yang, Cheng-Ta; Chong, Inn-Wen; Lin, Yu-Ching; Hsia, Te-Chun; Lin, Meng-Chih; Su, Wu-Chou; Lin, Chih-Bin; Lee, Kang-Yun; Wei, Yu-Feng; Lan, Gong-Yau; Chan, Wing P; Wang, Kao-Lun; Wu, Mei-Han; Tsai, Hao-Hung; Chian, Chih-Feng; Lai, Ruay-Sheng; JIN-YUAN SHIH ; Wang, Chi-Liang; Hsu, Jui-Sheng; Chen, Kun-Chieh; Chen, Chun-Ku; Hsia, Jiun-Yi; Peng, Chung-Kan; Tang, En-Kuei; CHIA-LIN HSU ; Chou, Teh-Ying; Shen, Wei-Chih; Tsai, Ying-Huang; Tsai, Chun-Ming; Chen, Yuh-Min; Lee, Yu-Chin; Chen, Hsuan-Yu; SUNG-LIANG YU ; Chen, Chien-Jen; Wan, Yung-Liang; Hsiung, Chao Agnes; PAN-CHYR YANG | The Lancet. Respiratory medicine | 6 | | |
2009 | Low-Dose Spiral Ct Screen for Lung Cancer in Patients with High Family Risk | TSAI, YING-HUANG; CHEUNG, YUN-CHUNG; NI, YUNG-LUN; YANG, PAN-CHYR; CHANG, GEE-CHEN | JOURNAL OF THORACIC ONCOLOGY | | | |
2015 | Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial). | Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan | J. Clin. Oncol. | | | |
2015 | Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial). | Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
2015 | Maintenance with Gefitinib/Pemetrexed (G/P) or P After Induction P/Platinum for Stage IV Lung Adenocarcinoma with No Sensitizing EGFR Mutation | Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin | J. Thorac. Oncol. | | | |
2015 | Maintenance with Gefitinib/Pemetrexed (G/P) or P After Induction P/Platinum for Stage IV Lung Adenocarcinoma with No Sensitizing EGFR Mutation | Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan | J. Thorac. Oncol. | | | |
2021 | MITF functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic role | Hsiao, Yi-Jing; Chang, Wen-Hsin; Chen, Hsuan-Yu; Hsu, Yin-Chen; Chiu, Su-Chin; Chiang, Ching-Cheng; Chang, Gee-Chen; Chen, Yi-Ju; Wang, Chia-Yu; Chen, Yan-Ming; Lin, Chien-Yu; Chen, Yu-Ju; PAN-CHYR YANG ; Chen, Jeremy J W; SUNG-LIANG YU | Aging | 6 | 0 | |
2020 | An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan | SHANG-GIN WU ; Chiang, Chi-Lu; Liu, Chien-Ying; Wang, Chin-Chou; Su, Po-Lan; Hsia, Te-Chun; JIN-YUAN SHIH ; Chang, Gee-Chen | Frontiers in Oncology | 23 | 23 | |
2016 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma | Su, Te-Jen; Ku, Wen-Hui; Chen, Hsuan-Yu; Hsu, Yi-Chiung; Hong, Qi-Sheng; Chang, Gee-Chen; Yu, Sung-Liang; Chen, Jeremy J. W. | Am. J. Cancer Res. | | | |
2009 | An Open-Label Single-Arm Phase Iv Study of Pemetrexed in Taiwanese Patients with Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy | CHANG, GEE-CHEN; TSAI, CHUN-MING; HSIA, TE-CHUN; YANG, CHIH-HSIN | JOURNAL OF THORACIC ONCOLOGY | | | |
2022 | PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients | Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen | Scientific reports | 11 | 9 | |
2023 | Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan | Blechter, Batel; Chien, Li-Hsin; Chen, Tzu-Yu; Chang, I-Shou; Choudhury, Parichoy Pal; Hsiao, Chin-Fu; Shu, Xiao-Ou; Wong, Jason Y Y; KUAN-YU CHEN ; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Huang, Ming-Shyan; Chen, Yuh-Min; Chen, Chih-Yi; Hung, Hsiao-Han; Hu, Jia-Wei; Shi, Jianxin; Zheng, Wei; Rositch, Anne F; Chen, Chien-Jen; Chatterjee, Nilanjan; PAN-CHYR YANG ; Rothman, Nathaniel; Hsiung, Chao Agnes; Lan, Qing | JAMA network open | 0 | 0 | |
2020 | Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model | Chien, Li-Hsin; Chen, Chung-Hsing; Chen, Tzu-Yu; Chang, Gee-Chen; Tsai, Ying-Huang; Hsiao, Chin-Fu; KUAN-YU CHEN ; Su, Wu-Chou; Wang, Wen-Chang; Huang, Ming-Shyan; Chen, Yuh-Min; Chen, Chih-Yi; SHENG-KAI LIANG ; CHUNG-YU CHEN ; Wang, Chih-Liang; Lee, Mei-Hsuan; Chung, Ren-Hua; Tsai, Fang-Yu; Hu, Jia-Wei; Katki, Hormuzd A; Chatterjee, Nilanjan; Chanock, Stephen J; Rothman, Nathaniel; Lan, Qing; PAN-CHYR YANG ; Chen, Chien-Jen; Chang, I-Shou; Hsiung, Chao A | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 26 | 23 | |
2024 | Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib | Wu, Jia-Jun; Tseng, Jeng-Sen; Zheng, Zhe-Rong; Chu, Cheng-Hsiang; Chen, Kun-Chieh; MONG-WEI LIN ; Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU ; JIN-SHING CHEN ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 0 | | |
2021 | Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients | Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU ; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen | OncoTargets and therapy | 6 | 6 | |
2021 | Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment | Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Chang, Gee-Chen | Oncology | 9 | 9 | |
2021 | Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers | SHENG-KAI LIANG ; Chien, Li-Hsin; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Chen, Yuh-Min; Huang, Ming-Shyan; Lin, Hsien-Chih; Fang, Wen-Tsen; Hung, Hsiao-Han; Jiang, Shih-Sheng; Chen, Chih-Yi; KUAN-YU CHEN ; Chang, I-Shou; Hsiung, Chao A; Chen, Chien-Jen; PAN-CHYR YANG | Frontiers in oncology | 4 | 4 | |